Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This trial is looking at azacitidine (also known as Vidaza) for people with low risk myelodysplastic syndrome.
Recruitment start: 1 August 2013
Recruitment end: 30 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor P Vyas
Celgene
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 11 June 2018
CRUK internal database number: 11177
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
